3D-Image-guided brachytherapy for Locally Advanced Cervical Cancer (Cervix-V)
Not Applicable
Completed
- Conditions
- Squamous cell carcinoma of the uterine cervix, Stage IIB (>4 cm in diameter) and IIIB disease
- Registration Number
- JPRN-UMIN000027578
- Lead Sponsor
- ational Institutes for Quantum and Radiological Sciences and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe concomitant illness 2. History of other malignancies within the past 5 years except basal cell carcinoma or squamous cell carcinoma in-situ of the skin 3. Tumor with infiltration of lower 1/3 of the vagina 4. Patients who are pregnant or lactating
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie 3D-image-guided brachytherapy efficacy in locally advanced cervical cancer?
How does 3D-image-guided brachytherapy compare to conventional brachytherapy in treating Stage IIB/IIIB cervical cancer?
What biomarkers are associated with improved outcomes in patients receiving 3D-image-guided brachytherapy for cervical cancer?
What are the potential adverse events and management strategies for 3D-image-guided brachytherapy in locally advanced cervical cancer?
Are there combination therapies or competitor approaches to 3D-image-guided brachytherapy for Stage IIB/IIIB squamous cell cervical carcinoma?